Imidazo[1,2-<i>a</i>]quinoxalines Derivatives Grafted with Amino Acids: Synthesis and Evaluation on A375 Melanoma Cells
Imiqualines (imidazoquinoxaline derivatives) are anticancer compounds with high cytotoxic activities on melanoma cell lines. The first generation of imiqualines, with two lead compounds (EAPB0203 and EAPB0503), shows remarkable in vitro (IC<sub>50</sub> = 1 570 nM and IC<sub>50<...
Main Authors: | Adrien Chouchou, Cindy Patinote, Pierre Cuq, Pierre-Antoine Bonnet, Carine Deleuze-Masquéfa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/23/11/2987 |
Similar Items
-
[1,2,4]triazolo[4,3-<i>a</i>]quinoxaline as Novel Scaffold in the Imiqualines Family: Candidates with Cytotoxic Activities on Melanoma Cell Lines
by: Cindy Patinote, et al.
Published: (2023-07-01) -
Design and Synthesis of Non-Covalent Imidazo[1,2-<i>a</i>]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment
by: Manvendra Kumar, et al.
Published: (2021-03-01) -
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-<i>a</i>]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice
by: Zahid Rafiq Bhat, et al.
Published: (2022-08-01) -
Synthesis of Functionalized 3<i>H</i>-pyrrolo-[1,2,3-<i>de</i>] Quinoxalines via Gold-Catalyzed Intramolecular Hydroamination of Alkynes
by: Antonia Iazzetti, et al.
Published: (2023-08-01) -
Quinoxaline Moiety: A Potential Scaffold against <i>Mycobacterium tuberculosis</i>
by: Marc Montana, et al.
Published: (2021-08-01)